Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

56.67
+0.34000.60%
Post-market: 56.670.00000.00%19:15 EDT
Volume:2.00M
Turnover:114.07M
Market Cap:7.93B
PE:38.42
High:58.64
Open:57.16
Low:56.24
Close:56.33
52wk High:76.76
52wk Low:9.57
Shares:140.01M
Float Shares:120.00M
Volume Ratio:0.70
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.48
EPS(LYR):-0.0122
ROE:75.50%
ROA:14.35%
PB:13.96
PE(LYR):-4,647.75

Loading ...

A Look At Arrowhead Pharmaceuticals (ARWR) Valuation As Fisher Builds Stake And SHASTA Readouts Approach

Simply Wall St.
·
Mar 19

Assessing Arrowhead Pharmaceuticals (ARWR) Valuation As Its RNAi Pipeline Advances To Phase 3 With Big Pharma Partners

Simply Wall St.
·
Mar 02

H.C. Wainwright Reaffirms Their Buy Rating on Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Feb 26

Arrowhead Pharmaceuticals to Join TD Cowen 46th Annual Health Care Conference Fireside Chat

Reuters
·
Feb 24

Arrowhead Pharmaceuticals Price Target Maintained With a $100.00/Share by HC Wainwright & Co.

Dow Jones
·
Feb 10

Arrowhead Pharmaceuticals Earnings Call Flags Pivotal 2026

TIPRANKS
·
Feb 08

Arrowhead price target lowered to $78 from $81 at Morgan Stanley

TIPRANKS
·
Feb 06

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Resmed (RMD) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Feb 06

U.S. RESEARCH ROUNDUP-Amazon, Estée Lauder, Ralph Lauren

Reuters
·
Feb 06

Arrowhead   Pharmaceuticals  misses Q1 revenue estimates

Reuters
·
Feb 06

Stock Track | Arrowhead Pharmaceuticals Plummets 5.88% Intraday After Missing Q1 Revenue Estimates

Stock Track
·
Feb 06

Arrowhead steigert Umsatz im ersten Quartal 2026 auf 264,03 Mio. USD um mehr als das 100-Fache

Reuters
·
Feb 06

BRIEF-Arrowhead Pharmaceuticals Q1 EPS USD 0.22

Reuters
·
Feb 06

Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results

THOMSON REUTERS
·
Feb 06

BUZZ-ADT rises ahead of S&P SmallCap addition

Reuters
·
Feb 05

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 05

Ciena Set to Join S&P500

MT Newswires Live
·
Feb 05

Arrowhead to replace Ciena in S&P 400 at open on 2/9

TIPRANKS
·
Feb 05

Earning Preview: Arrowhead Pharmaceuticals — revenue is expected to increase, and institutional views tilt positive

Earnings Agent
·
Jan 29

BUZZ-Arrowhead rises as it begins trial of high-cholesterol disorder drug

Reuters
·
Jan 27